Antibacterial activities of macrolactin a and 7-O-succinyl macrolactin a from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus

Archives of Pharmacal Research

Volumn 34, Issue 1, 2011, Pages 147-152

  Kim, Dong Hee ^a   Kim, Hye Kyung ^b   Kim, Kang Min ^c   Kim, Chun Kyu ^c   Jeong, Min Ho ^d   Ko, Chan Young ^e   Moon, Kyung Ho ^f   Kang, Jae Seon ^f  

^a Research and Development Center   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Inje University   (South Korea)

^d Dong A University   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Kyungsung University   (South Korea)

Author keywords

7 O succinyl macrolactin A; Antibacterial activity; Macrolactin A; Vancomycin resistant enterococci, Methicillin resistant Staphylococcus aureus

Indexed keywords

7 O SUCCINYL MACROLACTIN A; ANTIBIOTIC AGENT; LINEZOLID; MACROLACTIN A; TEICOPLANIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS; BACILLUS POLYFERMENTICUS; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; ENTEROCOCCAL INFECTION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS; ENTEROCOCCUS; FEMALE; INTESTINES; MACROLIDES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; TEICOPLANIN; VANCOMYCIN RESISTANCE;

EID: 79955050299     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0117-0     Document Type: Article

References (16)

1. A. J. Alanis 2005 Resistance to antibiotics: Are we in the postantibiotic era? Arch. Med. Res. 36 697 705 16216651 10.1016/j.arcmed.2005.06.009 (Pubitemid 41436239)
2. D. J. Biedenbach G. J. Moet R. N. Jones 2004 Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997-2002) Diagn. Microbiol. Infect. Dis. 50 59 69 15380279 10.1016/j.diagmicrobio.2004.05.003 1:CAS:528: DC%2BD2cXnslGjtb8%3D (Pubitemid 39360263)
3. N. M. Clark E. Hershberger M. J. Zervosc J. P. Lynch III 2003 Antimicrobial resistance among gram-positive organisms in the intensive care unit Curr. Opin. Crit. Care 9 403 412 14508154 10.1097/00075198-200310000-00011 (Pubitemid 37204796)
4. C. J. Donskey J. A. Hanrahan R. A. Hutton L. B. Rice 1999 Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract J. Infect. Dis. 180 384 390 10395853 10.1086/314874 1:CAS:528:DyaK1MXlt1ygsbg%3D (Pubitemid 30256319)
5. M. K. Hayden G. M. Trenholme J. E. Schultz D. F. Sahm 1993 In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate J. Infect. Dis. 167 1224 1227 8486959 10.1093/infdis/167.5.1224 1:CAS:528:DyaK3sXks1Oqs7w%3D (Pubitemid 23115622)
6. M. M. Huycke D. F. Sahm M. S. Gilmore 1998 Multipledrug resistant enterococci: the nature of the problem and an agenda for the future Emerg. Infect. Dis. 4 239 249 9621194 10.3201/eid0402.980211 1:STN:280: DyaK1c3osVaitg%3D%3D (Pubitemid 28311210)
7. Kang, J. S., Kim, C. G., Kim, D. H., Kim, K. M., Kim, D. H., Choi, G. J., Hong, J. S., and Hong, Y. G., Antibacterial macrolactin A that Bacillus polyfermenticus KJS-2 produced in. Patent WO 2008/114954 A1 (2008).
8. K. M. Kim M. J. Kim D. H. Kim Y. S. Park J. S. Kang 2009 Characterization of Bacillus polyfermenticus KJS-2 as a probiotic J. Microbiol. Biotechnol. 19 1013 1018 19809260 10.4014/jmb.0903.113 1:CAS:528:DC%2BD1MXhtlansrnI
9. M. D. King B. J. Humphrey Y. F. Wang E. V. Kourbatova S. M. Ray H. M. Blumberg 2006 Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and softtissue infections Ann. Intern. Med. 144 309 317 16520471 (Pubitemid 46768185)
10. S.-J. Lee J.-Y. Cho J.-I. Cho J.-H. Moon K. D. Park Y.-J. Lee K.-H. Park 2004 Isolation and characterization of antimicrobial substance macrolactin A Produced from Bacillus amyloliquefaciens CHO104 isolated from soil J. Microbiol. Biotechnol. 14 525 531 1:CAS:528:DC%2BD2cXmtl2jt70%3D (Pubitemid 38979433)
11. M. Romero-Tabarez R. Jansen M. Sylla H. Lünsdorf S. Häussler D. A. Santosa K. N. Timmis G. Molinari 2006 7-O-Malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillinresistant Staphylococcus aureus, vancomycin-Resistant Enterococci, and a small-colony variant of Burkholderia cepacia Antimicrob. Agents Chemother. 50 1701 1709 16641438 10.1128/AAC.50.5.1701-1709.2006 1:CAS:528: DC%2BD28XksVKkt70%3D
12. U. Stiefel N. J. Pultz M. S. Helfand C. J. Donskey 2004 Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice Antimicrob. Agents Chemother. 48 2144 2148 15155213 10.1128/AAC.48.6.2144-2148.2004 1:CAS:528:DC%2BD2cXks1yqtL8%3D (Pubitemid 38691611)
13. K. G. Van Horn C. A. Gedris K. M. Rodney 1996 Selective isolation of vancomycin-resistant enterococci J. Clin. Microbiol. 34 924 927 8815109 (Pubitemid 26091508)
14. Wayne, Pa., National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed., p. 1-21 (1999).
15. H. Wisplinghoff T. Bischoff S. M. Tallent H. Seifert R. P. Wenzel M. B. Edmond 2004 Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin. Infect. Dis. 39 309 317 15306996 10.1086/421946 (Pubitemid 39050477)
16. A. Zirakzadeh R. Patel 2006 Vancomycin-resistant enterococci: colonization, infection, detection, and treatment Mayo Clin. Proc. 81 529 536 16610573 10.4065/81.4.529 1:CAS:528:DC%2BD28XjvFemsLg%3D